BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10395684)

  • 1. IL-2 mediates protection against abscess formation in an experimental model of sepsis.
    Tzianabos AO; Russell PR; Onderdonk AB; Gibson FC; Cywes C; Chan M; Finberg RW; Kasper DL
    J Immunol; 1999 Jul; 163(2):893-7. PubMed ID: 10395684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
    Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
    J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
    Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
    Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
    Lucas B; Bumann D; Walduck A; Koesling J; Develioglu L; Meyer TF; Aebischer T
    Infect Immun; 2001 Mar; 69(3):1714-21. PubMed ID: 11179348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 is essential for zwitterionic polysaccharide-mediated abscess formation.
    Meemboor S; Mertens J; Flenner E; Groneck L; Zingarelli A; Gamstätter T; Bessler M; Seeger JM; Kashkar H; Odenthal M; Kalka-Moll WM
    Innate Immun; 2010 Oct; 16(5):310-21. PubMed ID: 19897529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial structure and functional relation to abscess formation.
    Tzianabos AO; Onderdonk AB; Kasper DL
    Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The septic abscess wall: a cytokine-generating organ associated with portal venous cytokinemia, hepatic outflow fibrosis, sinusoidal congestion, inflammatory cell sequestration, hepatocellular lipid deposition, and focal cell death.
    Ceydeli A; Condon MR; Siegel JH
    Shock; 2003 Jul; 20(1):74-84. PubMed ID: 12813373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis.
    Song GY; Chung CS; Chaudry IH; Ayala A
    Surgery; 2000 Aug; 128(2):133-8. PubMed ID: 10922982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides.
    Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
    Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
    Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of T cells for cytokine production and outcome in a model of acute septic peritonitis.
    Reim D; Westenfelder K; Kaiser-Moore S; Schlautkötter S; Holzmann B; Weighardt H
    Shock; 2009 Mar; 31(3):245-50. PubMed ID: 18650777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2.
    Goronzy J; Weyand C; Quan J; Fathman CG; O'Hanley P
    J Immunol; 1989 Feb; 142(4):1134-8. PubMed ID: 2644349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.